Fulvidax 250mg Injection
Specialized Oncology Sourcing
Contact our pharmacy desk on WhatsApp or call for verified availability & exact price.

Free Express Cold-Chain Delivery
Temperature-controlled dispatch across India within 4 to 24 hours.
Financial Assistance Available
Contact our oncology support team to check your eligibility for manufacturer patient assistance programs (PAP) for Fulvidax 250mg Injection.

About this medicine
Fulvidax 250mg Injection (Fulvestrant (250mg))is a prescription oncology medicine. Below is educational product information — follow your doctor's advice for dose and use.
Fulvidax 250mg Injection is an estrogen blocker. It is used in the treatment of breast cancer in women who have gone through menopause. It works by adjusting the level of estrogen and slow down the growth of cancer cells.This medicine is given as an injection into the muscles under the supervision of a doctor. It should be taken as doctor your doctor's advice. The dose and how often you take it depends on what you are taking it for. Your doctor will decide how much you need to improve your symptoms. You should take this medicine for as long as it is prescribed for you.The most common side effects of this medicine include injection site reaction, headache, vomiting, allergic reaction, and nausea. If these bother you, or appear serious, let your doctor know. There may be ways of reducing or preventing them.Before taking this medicine, tell your doctor if you ever had kidney or liver disease or had bleeding disorder or had any blood clotting medicine. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works. Tell your doctor if you are pregnant, planning pregnancy or breastfeeding.
Quick Facts
Composition / Active Salt
Dosage Form
Injection
Prescription Status
Doctor's Rx Required
What if you miss a dose?
If you miss a dose of Fulvidax 250mg Injection, please consult your doctor.\n
Uses of Fulvidax 250mg Injection
Side Effects of Fulvidax 250mg Injection
Oncology medicines should be administered strictly under medical supervision. Inform your oncologist immediately if you experience adverse symptoms.
Clinical Safety Advice for Fulvidax 250mg Injection
Follow expert clinical guidelines regarding interactions, precautions, and medical conditions when taking Fulvidax 250mg Injection.
Caution is advised when consuming alcohol with Fulvidax 250mg Injection. Please consult your doctor.
Fulvidax 250mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Fulvidax 250mg Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Fulvidax 250mg Injection does not usually affect your ability to drive.
Fulvidax 250mg Injection should be used with caution in patients with severe kidney disease. Dose adjustment of Fulvidax 250mg Injection may be needed. Please consult your doctor.Limited information is available on the use of Fulvidax 250mg Injection in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
Fulvidax 250mg Injection should be used with caution in patients with liver disease. Dose adjustment of Fulvidax 250mg Injection may be needed. Please consult your doctor.
Cold-Chain Temperature Protocol
Temperature-controlled cold-chain dispatch for Fulvidax 250mg Injection across India, with express delivery in Delhi NCR, Noida, and Ghaziabad.
Temperature Monitoring
Sourced from certified cold-storage warehouses.
Insulated Transit
Dispatched in gel-ice thermal insulated boxes.
Rx Verification
Prescription validated prior to cold dispatch.
Frequently Asked Questions
Have questions about your cancer prescription?
Our licensed oncology pharmacists are available to assist with medicine availability, cold-chain handling, and prescription verification.